SCHEMBL21189280

SCHEMBL21189280

O=C(Nc1ccc(F)c(Cl)c1)c1cccc2c1OCCC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.54
NPSR1 Q6W5P4 1/20 0.51
MAPT P10636 6/20 0.50
LMNA P02545 2/20 0.50
NPC1 O15118 8/20 0.49
RAB9A P51151 8/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 2/20 0.48
TP53 P04637 2/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 3/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PTGES O14684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973573 0.86 FADS1 (0.53) FADS1NPSR1MAPTLMNANPC1
SCHEMBL15786683 0.85 FADS1 (0.55) FADS1NPSR1MAPTLMNANPC1
SCHEMBL21189493 0.84 SMN1; SMN2 (0.55) FADS1NPSR1MAPTLMNANPC1
SCHEMBL19991462 0.84 MAPT (0.46) NPSR1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL15786675 0.83 NPC1 (0.58) FADS1NPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL26705884 0.81 FADS1 (0.58) FADS1NPSR1MAPTLMNANPC1
SCHEMBL17208120 0.81 FADS1 (0.58) FADS1NPSR1MAPTLMNANPC1
SCHEMBL19973617 0.78 FADS1 (0.54) FADS1NPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL19973619 0.78 FADS1 (0.54) FADS1NPSR1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL19973564 0.77 FADS1 (0.53) FADS1NPSR1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS FADS1 2483/4885NPSR1 4645/4885MAPT 3165/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS FADS1 2483/4885NPSR1 4645/4885MAPT 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.